Related Experiment Video
Updated: Jul 14, 2025

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Disseminated Histoplasmosis in Central California Seen in an Immunocompromised Patient
Kishan Ghadiya1, Robert Dunn1, Gurpal Singh1
1UCLA-Kern Medical, Bakersfield, CA, USA.
Abstract:
Histoplasma capsulatum is a dimorphic fungus found in certain parts of North, Central, and South America. Transmission is primarily through airborne inoculation from inhaled fungal microconidia. Histoplasmosis is typically a self-limited mycosis; however, in patients with immunodeficiency, disseminated disease can occur and may lead to high disease burden. This report studies a case of disseminated histoplasmosis in a patient newly diagnosed with human immunodeficiency virus. His presentation on admission was consistent with infectious pulmonary granulomatous disease, and further imaging and laboratory results showed evidence of multi-organ involvement. It is likely his presentation in Central California was a reactivation infection after inoculation in Central America many years ago.
Insights
Disseminated histoplasmosis, a fungal infection, occurred in an HIV-positive patient. Reactivation of a past infection likely caused severe, multi-organ disease in California.
Area of Science:
- Mycology
- Infectious Diseases
- Immunology
Background:
- Histoplasma capsulatum is a fungus endemic to the Americas, causing histoplasmosis via inhaled microconidia.
- Histoplasmosis is usually self-limiting but can disseminate in immunocompromised individuals, leading to significant morbidity.
Observation:
- A case study of a patient newly diagnosed with human immunodeficiency virus (HIV) presenting with disseminated histoplasmosis.
- The patient's symptoms mimicked infectious pulmonary granulomatous disease, with imaging revealing multi-organ involvement.
Findings:
- The patient's disseminated histoplasmosis was diagnosed in Central California.
- Evidence suggests a reactivation of a prior infection acquired in Central America, potentially years earlier.
Implications:
- Highlights the risk of disseminated histoplasmosis in newly diagnosed HIV patients.
- Suggests the possibility of late reactivation of endemic fungal infections in immunocompromised individuals.
- Emphasizes the importance of considering endemic mycoses in differential diagnoses, even in non-endemic areas.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Fungal Phylum Microsporidia

